Author

A. Lemckert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. H. Baker· 1 shared C. van der Zalm· 1 shared G. L. Kajan· 1 shared H. M. van der Schaar· 1 shared J. Custers· 1 shared L. John· 1 shared M. Havenga· 1 shared M. Z. Ballmann· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. H. Baker

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development

M. Z. Ballmann, S. Raus, R. Engelhart, G. L. Kajan, C. van der Zalm, T. Papp, L. John, S. Khan, J. Custers, W. A. M. Bakker, H. M. van der Schaar, N. Arnberg, A. Lemckert, M. Havenga, A. H. Baker

This paper describes the development of a novel adenoviral vector, HAdV-20-42-42, which shows promise for gene therapy and vaccination due to its low seroprevalence and effective transduction capabilities.

bioRxiv · Mar 11, 2021Immunology